跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
BUDESONIDE
Authorized
STANDARD
BUDESONIDE
Tillotts Pharma Ag
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f3c968084a9c69cd
Company
Tillotts Pharma Ag
Type
Standard
Approval Details
Approval Id
f3c968084a9c69cd
Drug Approval Canada Name
BUDESONIDE
Product Name
BUDESONIDE
Status
Dormant
Status Date
2024-07-31
Original Market Date
2020-01-17
Din
02483874
Drug Class
Human
Dosage Form
Capsule (Sustained-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:04.00
Atc Original
A07EA06 BUDESONIDE
Atc Name
a 07 ea 06
Aig Number
0116807006
Company Name
Tillotts Pharma Ag
Company Address
Warmbacher Strasse 80, Rheinfelden, Baden-Wuerttemberg, Germany, 79618
Company Detail Path
/organization/tillotts-pharma-ag
Company Information
Pharmaceutical Company Name
Tillotts Pharma Ag
Country Name
Sweden
Address
Utländsk Adr - Foreign Addr
Website
http://www.tillotts.com
Active Ingredients
BUDESONIDE
3 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f3c968084a9c69cd
Type
Standard
Back to Health Canada Approvals
BUDESONIDE - Health Canada Drug Approval Details